Cancers mimicking fungal infections.

Adv Skin Wound Care

Barry Ladizinski, MD, is an MPH/MBA candidate at Johns Hopkins University, Baltimore, Maryland. Afsaneh Alavi, MD, is a Dermatology and Wound Care Consultant at the Women's College Hospital and the University of Toronto, Ontario, Canada. Jay Jambrosic, MD, is a Dermatopathology Consultant at the Women's College Hospital, University of Toronto, and Life Lab Dermatopathology, Toronto. Nisha Mistry, MD, is Adjunct Lecturer at the University of Toronto. R. Gary Sibbald, MD, MEd, BSc, FRCPC(Med Derm), MACP, FAAD, MAPWCA, is Professor of Public Health and Medicine, University of Toronto, Ontario, Canada; Director, International Interprofessional Wound Care Course & Masters of Science in Community Health (Prevention & Wound Care), Dalla Lana School of Public Health, University of Toronto; Past President, World Union of Wound Healing Societies; Course Coordinator, International Interprofessional Wound Care Course at New York University Medical Center, and Clinical Editor, Advances in Skin & Wound Care, Philadelphia, Pennsylvania. Dr Ladizinski has disclosed that he has no financial relationships related to this article. Dr Alavi has disclosed that she was a consultant to Galderma, Valeant, and Abbott and was renumerated for travel expenses from Leo and Stiefel Laboratories. Dr Jambrosic has disclosed that he is employed by Ontario Health Insurance Canada, and he has provided expert testimony for the Canadian Medical Protective Association. Dr Mistry has disclosed that she is a consultant to Abbott and Janssen; was a member of the speakers' bureau for Galderma, Leo, and Triton; and was a member of the speakers' bureau for Valeant and Valeo. Dr Sibbald has disclosed that he is a board member of 3M, BSN, Coloplast, Covidien, Gaymar, KCI, Systagenix, Mölnlycke, Registered Nurses Association of Ontario, Hollister Limited, and Healthpoint; was a member of the speakers' bureau for 3M, BSN, Coloplast, Gaymar, KCI, Systagenix, Mölnlycke, Hollister Limited, Valeant, and Stiefel Lab

Published: July 2014

Primary and metastatic malignancies may occasionally mimic or coexist with cutaneous fungal infections. The authors report 3 cases of cancers that were initially presumed to be cutaneous fungal infections. Dermatologists should maintain a low threshold for skin biopsy in patients with persistent or refractory fungal infections.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ASW.0000446864.26807.43DOI Listing

Publication Analysis

Top Keywords

fungal infections
16
cutaneous fungal
8
cancers mimicking
4
fungal
4
mimicking fungal
4
infections
4
infections primary
4
primary metastatic
4
metastatic malignancies
4
malignancies occasionally
4

Similar Publications

Donor-derived Cryptococcus gattii complex infection after liver transplantation.

Rev Soc Bras Med Trop

January 2025

Universidade Federal do Paraná, Departamento de Clínica Médica, Programa de pós-graduação em Medicina Interna e Ciências da Saúde, Curitiba, PR, Brasil.

Cryptococcal disease is the third most common invasive fungal infection in solid organ transplant recipients and is associated with high-morbidity and -mortality rates. Donor-derived Cryptococcus spp. infection typically manifests within the first month post-procedure and has historically been caused by C.

View Article and Find Full Text PDF

Intracameral voriconazole for severe fungal keratitis: a case series.

Arq Bras Oftalmol

January 2025

Department of Ophthalmology and Visual Sciences, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brazil.

Purpose: This study aimed to report the use, efficacy, and safety of intracameral voriconazole as an adjuvant treatment for deep fungal keratitis.

Methods: This was a prospective case series of seven eyes with fungal keratitis with anterior chamber involvement or a corneal ulcer refractory to conventional topical treatment. In addition to topical treatment with 0.

View Article and Find Full Text PDF

Candida auris is an emerging, multidrug-resistant fungus that poses a threat in health care settings because of its persistence on surfaces and ability to cause severe infections, particularly in immunocompromised patients. First identified in Japan in 2009, C auris has since spread globally, leading to numerous outbreaks. Its unique virulence factors, such as biofilm formation and immune evasion, contribute to its resilience and resistance to eradication.

View Article and Find Full Text PDF

[Investigation of the Antifungal Susceptibility and Virulence Factors of Fusarium Strains Isolated from Clinical Samples].

Mikrobiyol Bul

January 2025

Aydın Adnan Menderes Üniversitesi Tıp Fakültesi, Tıbbi Mikrobiyoloji Anabilim Dalı, Aydın.

Fusarium türleri, insanlarda keratit ve onikomikoz başta olmak üzere invaziv veya invaziv olmayan çeşitli enfeksiyonlarda etken olan küf mantarlarıdır. Taksonomide Fusarium cinsi, tür kompleks [species complex (SC)]'lere ayrılmış, SC'ler de türlere ayrılmıştır. SC/tür düzeyinde identifikasyonun, morfolojik özelliklere göre yapılmasının güçlüğü nedeniyle moleküler yöntemlerin kullanımı önerilmektedir.

View Article and Find Full Text PDF

Antifungal activity of 2-adamantylamine hydrochloride on and .

J Med Microbiol

January 2025

Department of Stem Cell and Regenerative Medicine, Medical Biotechnology, Centre for Interdisciplinary Research, D.Y. Patil Education Society (Deemed to be University), Kolhapur- 416-003, Maharashtra, India.

Increased virulence and drug resistance in species of resulted in reduced disease control and further demand the development of potent antifungal drugs. The repurposing of non-antifungal drugs and combination therapy has become an attractive alternative to counter the emerging drug resistance and toxicity of existing antifungal drugs against and non-albicans species. This study aimed to accelerate antifungal drug development process by drug repurposing approach.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!